1. From The Hull Family Cardiac Fibrillation Management Laboratory (K.U., K.N., S.M., K.N.), Toronto General Hospital, Toronto, Canada; Ryerson University (K.U., S.K.), Toronto, Canada; University of Alabama at Birmingham (J.R.), Birmingham, Ala; and the University of Auckland (M.P.N.), Auckland, New Zealand.